Blog
RSS FeedPosted by Michael Wonder on 05 Mar 2021
PBAC Public Summary Documents - November 2020 meeting
5 March 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2020 PBAC ...
Posted by Michael Wonder on 04 Mar 2021
AstraZeneca CEO Pascal Soriot says vaccine is 100 per cent effective
5 March 2021 - The global head of AstraZeneca has declared the company’s vaccine is 100 per cent effective against ...
Posted by Michael Wonder on 04 Mar 2021
Ofev (nintedanib) receives positive recommendation from CADTH and INESSS for the treatment of progressive fibrosing interstitial lung diseases
4 March 2021 - Ofev is the first treatment available in Canada for chronic fibrosing interstitial lung diseases with a progressive ...
Posted by Michael Wonder on 04 Mar 2021
Italy, EU refuse AstraZeneca request to ship 250,000 doses of vaccine to Australia
5 March 2021 - Italy and the European Union have blocked a shipment of the Oxford-AstraZeneca coronavirus vaccine destined for Australia ...
Posted by Michael Wonder on 04 Mar 2021
PHARMAC swapping epilepsy drugs 'cannot be discounted' as a cause of deaths — neurologist
4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug ...
Posted by Michael Wonder on 04 Mar 2021
The PHARMAC non-review?
4 March 2021 - The recently announced PHARMAC review is fatally flawed. ...
Posted by Michael Wonder on 04 Mar 2021
NICE rejects rare blood cancer treatment Poteligeo in final appraisal
4 March 2021 - The UK’s NICE has not recommended Kyowa Kirin’s Poteligeo for the treatment of adults living with ...
Posted by Michael Wonder on 03 Mar 2021
Cancer patient told palliative care only option after being rejected PHARMAC funding
2 March 2021 - The drug-buying agency was placed under an independent review today after the Prime Minister said she ...
Posted by Michael Wonder on 03 Mar 2021
PHARMAC ripe for reassessment
3 March 2021 - New Zealand’s drug buying agency PHARMAC has long been, simultaneously, a good thing in itself and ...
Posted by Michael Wonder on 03 Mar 2021
CSL warns AstraZeneca booster shots not available until end of year
2 March 2021 - Australia’s COVID-19 vaccine maker CSL says it is open to making booster shots for AstraZeneca for ...
Posted by Michael Wonder on 03 Mar 2021
NICE backs NHS use of Lilly’s Olumiant in eczema
3 March 2021 - Eli Lilly’s Olumiant has received a UK NICE recommendation for the treatment of moderate-to-severe atopic dermatitis ...
Posted by Michael Wonder on 02 Mar 2021
NHS prescription charges set to rise in England
2 March 2021 - The NHS prescription charge in England is set to increase to £9.35 from 1 April 2021 ...
Posted by Michael Wonder on 02 Mar 2021
Government announces review into PHARMAC
2 March 2021 - The Government is following through on an election promise to conduct an independent review into PHARMAC, ...
Posted by Michael Wonder on 02 Mar 2021
Medicines New Zealand supportive of Government’s PHARMAC review assuming it is not a box-ticking exercise
2 March 2021 - Medicines New Zealand is supportive of the proposed review into PHARMAC if it is intended to improve ...
Posted by Michael Wonder on 01 Mar 2021
Review asks how Government can get the new drugs it wants funded
2 March 2021 - The much-vaunted PHARMAC inquiry, being announced today, will investigate how the drug-buying agency can be brought ...